Effect of the Utilization of Pharmaceutical Care Tools developed to Manage Preventable Adverse Drug Events in General Surgical Patients
Main Article Content
Abstract
Objective: To compare the incidence of (preventable adverse drug events; pADEs) before and after implementation of tools developed for pharmaceutical care in general surgical patients. Methods: Subjects were all male patients admitted to male general surgical ward at Songkhla hospital with a hospital stay at least 24 hours. Prior to the development of tools for pharmaceutical care, the researchers prospectively collected the data to detect pADEs by reviewing medical records, interviewing patients and health care professionals, observing on the ward, and reviewing voluntary incident reports by health care professionals. Two reviewers including a physician and a clinical pharmacist independently judged whether identified incidents were pADEs. Subsequently the researchers analyzed the information on pADEs, developed pharmaceutical care tools accordingly and implemented them in practice. The tools developed during implementation of pharmaceutical care tool period were implemented along with pharmaceutical care service. The data collection after implementation of the tools was done in the same way as that of pre-tool development phase. Primary outcome was the incidence of pADEs. Results: In the phases of pre and post implementation of the tools, there were 247 patients with 1,628 patient-days and 231 patients with 1,298 patient-days, respectively. The developed tools included warfarin protocol, warfarin dosing chart, warfarin monitoring sheet, warfarin note, medication reconciliation (MR) order form, MR sticker and potassium chloride elixir pre-printed sticker. The incidence rates of pADEs decreased from 3.07 per 1,000 patient-days in the pre-tool implementation phase to 0 in the post tool implementation phase (P = 0.030). Most of the pADEs identified during pre-tool implementation phase were in the category E. Conclusion: The analysis of identified pADEs and corresponding tools development to resolve the problems at system level were effective to decrease the incidence of pADEs.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Martins ACM, Giordani F, Rozenfeld S. Adverse events among adult inpatients: a meta-analysis of observational studies. J Clin Pharm Ther 2014; 39: 609-20.
3. Boeker EB, Ram K, Klopotowska JE, de Bore M, Creus MT, de Andres AL, et al. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients. Br J Clin Pharmacol 2014; 79: 548-57.
4. de Bore M, Boeker BE, Ramrattan MA, Kiewiet S. JJ, Ram K, Gombert-Handoko KB, et. al. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study). Br J Surg 2015; 102: 1204–12.
5. González-García L, Salmerón-García A, García-Lirola M, Moya-Roldán S, Belda-Rustarazo S, Cabeza-Barrera J. Medication reconciliation at admission to surgical departments. J Eval Clin Pract 2016; 22: 20–5.
6. Griffin FA, Resar RK. IHI global trigger tool for measuring adverse events (second edition) [online]. 2009. [cited July 23, 2016]. Available from: www. IHI.org
7. Jariyapongpaiboon P. Pharmaceutical care for general surgical male patients in Chang Rai regional hospital [master thesis]. Bangkok: Chula longkorn university; 1996.
8. Punpho P. Pharmaceutical care for general surgical male patients in Maharat Nakhon Ratchasima hospital. [master thesis]. Bangkok: Chulalongkorn university; 2002.
9. Weant KA, Bailey AM, Baker SN. Strategies for reducing medication errors in the emergency department [editorial]. Emerg Med 2014; 45 - 55.
10. Ningsanon T, Yothapitak J. Guidelines of adverse drug reactions monitoring. Bangkok: Poramatkarn pim; 2016.
11. Yothapitak J, Songsiriphan R. Principle, common event and prevention of preventable ADR. In: Ningsanon T, Yothapitak J, editors. Relevancy of adverse drug reaction. Bangkok: Poramatkarnpim; 2006. p. 57-94.
12. Yothapitak J. Role of pharmacist in preventing adverse drug reactions. In: Chulawathanathon W, Monthakarnthikul P, Jindawijak B, Suksomboon N, Saunsane T, (editors). Pharmaceutical quality system. Bangkok: Prachachon; 2006. p. 19-30.
13. Supachutikul A, Anakamanee K. HA update 2017. Nontaburi: Nangseodeewan; 2017. p 153-9.
14. de Boer M, Boeker BE, Ramrattan MA, Kiewiet S. JJ, Dijkgraaf W. MG, Boermeester MA, et. al. Adverse drug events in surgical patients: an obser vational multicenter study. Int J Clin Pharm 2013; 35: 744–52.
15. Morimoto T, Sakuma M, Matsui K, Kuramoto N, Toshiro J, Murakami J, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med 2011; 26: 148–53.
16. Association of Hospital Pharmacy (Thailand). Position statement: Acute pharmaceutical care. In: Jindawijak B, Saunsane T, editors. The flourishing pharmacy profession: continuity of pharmaceutical care. Bangkok: Prachachon; 2013. p. 227-8.
17. Kania J, Kramer M. Collective Impact [online]. 2011 [cited Jan 13, 2018]. Available from: www.ma gnoliaplacela.org/wp-content/uploads/2016/07/Colle ctive-Impact.pdf
18. Kunchaimuang S. Collective Impact [online]. 2015 [cited Jan 13, 2018]. Available from: www.image plus.co.th/upload/files/1443760081_1.pdf.